It is promising to note that following cessation of CDK4/6i treatment, therapy-induced transcriptional reprogramming in T cells is stable for up to 30 days in mice16; although further studies are needed to determine the stability of CDK4/6i-induced transcriptional changes in tumor cells. This evidence concerns the gene CDK4 and neoplasm.